US authorises J&J’s single-dose vaccine

Washington : The US drugs regulator has granted emergency use authorisation to Johnson & Johnson’s single-dose Covid-19 jab, making it the third vaccine in the country’s fight against the pandemic.

The other vaccines already in use are from Pfizer-BioNTech and Moderna, both needing two doses. J&J’s vaccine is also easier to store and transport as it doesn’t need to be kept frozen.

“The authorisation of this vaccine expands the availability of vaccines, the best medical prevention method for Covid-19, to help us in the fight against this pandemic,” said Janet Woodcock of the US Food and Drug Administration (FDA).

The FDA said the vaccine is about 67% effective in preventing moderate to severe/critical Covid-19 occurring at least 14 days after vaccination. 


Comments

Popular posts from this blog

Golden Globes to launch a pandemic-era Hollywood awards season

Modi urges use of Indian goods

Bumrah released from team over ‘personal reasons’, to miss 4th Test